Interestingly, among the genetic variants that were discovered to have an effect on post-mortem MS lesion characteristics, it was found that rs5742909/CTLA-4 was associated with the proportion of remyelinated lesions [130]. The gene discussed is CTLA4; the disease is myeloid sarcoma.